According to the research report, the global revenuecycle management market size is expected to touch USD 135.12 Billion by 2030, from USD 65.96 Billion in 2021, growing with a significant CAGR of 12.2% from 2022 to 2030.
The revenue cycle management market report
offers a comprehensive study of the current state expected at the major
drivers, market strategies, and key vendors’ growth. The report presents
energetic visions to conclude and study the market size, market hopes, and
competitive surroundings. The research also focuses on the important
achievements of the market, research & development, and regional growth of
the leading competitors operating in the market. The current trends of the
global revenue cycle management market in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global revenue cycle management market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global revenue cycle management market during the
forecast period. It also includes a key indicator assessment that highlights
growth prospects of this market and estimates statistics related to growth of
the market in terms of value (US$ Mn) and volume (tons).
Sample Link https://www.precedenceresearch.com/sample/1065
Report Highlights | Details |
Market Size | USD 135.12 Billion by 2027 |
Growth Rate | CAGR of 12.2% from 2021 to 2027 |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2021 |
Forecast Period | 2021 to 2027 |
Segments Covered | Deployment, Type, Offering, Application, Region |
This study covers a detailed segmentation
of the global revenue cycle management market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global revenue cycle management market, wherein
various developments, expansions, and winning strategies practiced and
implemented by leading players have been presented in detail.
Key Players
- Cerner Corporation
- McKesson Corporation
- Quest Diagnostics Incorporated
- Allscripts Healthcare Solutions
- Athenahealth
- CareCloud
- Emdeon
- The SSI Group Inc
- GE Healthcare
- Eclinicalworks
- Meditech
- Epic Systems
- Conifer Health Solutions
- Gebbs Healthcare Solutions
- Constellation Software
- Experian PLC
- NextGen Healthcare Information System LLC
Market Segmentation
- Web-Based
- On-Premise
- Cloud-Based
By Offering
- Services
- Software
By Type
- Standalone
- Integrated
By End User
- Hospitals
- Physician Offices
- Diagnostic Laboratories
- Others (Pharmacies, academic medical centers etc.)
By Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Research Methodology
The research methodology adopted by
analysts for compiling the global revenue cycle management market report is
based on detailed primary as well as secondary research. With the help of
in-depth insights of the market-affiliated information that is obtained and
legitimated by market-admissible resources, analysts have offered riveting
observations and authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global revenue cycle management market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Revenue Cycle Management Market, By Deployment
7.1. Revenue Cycle Management Market, by Deployment Type, 2020-2027
7.1.1. Web-Based
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. On-Premise
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Cloud-Based
7.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Revenue Cycle Management Market, By Offering
8.1. Revenue Cycle Management Market, by Offering, 2020-2027
8.1.1. Services
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Revenue Cycle Management Market, By Type
9.1. Revenue Cycle Management Market, by Type, 2020-2027
9.1.1. Standalone
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Integrated
9.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Revenue Cycle Management Market, By End-User
10.1. Revenue Cycle Management Market, by End-User, 2020-2027
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Physician Offices
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Diagnostic Laboratories
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Others (Pharmacies, academic medical centers etc.)
10.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 11. Global Revenue Cycle Management Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.1.2. Market Revenue and Forecast, by Offering (2016-2027)
11.1.3. Market Revenue and Forecast, by Type (2016-2027)
11.1.4. Market Revenue and Forecast, by End-User (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Offering (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.1.5.4. Market Revenue and Forecast, by End-User (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Offering (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.1.6.4. Market Revenue and Forecast, by End-User (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.2.2. Market Revenue and Forecast, by Offering (2016-2027)
11.2.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.4. Market Revenue and Forecast, by End-User (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Offering (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.5.4. Market Revenue and Forecast, by End-User (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.2.6.2. Market Revenue and Forecast, by Offering (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.6.4. Market Revenue and Forecast, by End-User (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Offering (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.7.4. Market Revenue and Forecast, by End-User (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Offering (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.8.4. Market Revenue and Forecast, by End-User (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.3.2. Market Revenue and Forecast, by Offering (2016-2027)
11.3.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.4. Market Revenue and Forecast, by End-User (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Offering (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.5.4. Market Revenue and Forecast, by End-User (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Offering (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.6.4. Market Revenue and Forecast, by End-User (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Offering (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.7.4. Market Revenue and Forecast, by End-User (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Offering (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.8.4. Market Revenue and Forecast, by End-User (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.4.2. Market Revenue and Forecast, by Offering (2016-2027)
11.4.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.4. Market Revenue and Forecast, by End-User (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Offering (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.5.4. Market Revenue and Forecast, by End-User (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Offering (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.6.4. Market Revenue and Forecast, by End-User (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Offering (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.7.4. Market Revenue and Forecast, by End-User (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Offering (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.8.4. Market Revenue and Forecast, by End-User (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.5.2. Market Revenue and Forecast, by Offering (2016-2027)
11.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.5.4. Market Revenue and Forecast, by End-User (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Offering (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.5.5.4. Market Revenue and Forecast, by End-User (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Deployment (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Offering (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.5.6.4. Market Revenue and Forecast, by End-User (2016-2027)
Chapter 12. Company Profiles
12.1. Cerner Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. McKesson Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Quest Diagnostics Incorporated
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Allscripts Healthcare Solutions
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Athenahealth
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. CareCloud
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Emdeon
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. The SSI Group Inc
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. GE Healthcare
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Eclinicalworks
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Meditech
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. Epic Systems
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Conifer Health Solutions
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. Gebbs Healthcare Solutions
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
12.15. Constellation Software
12.15.1. Company Overview
12.15.2. Product Offerings
12.15.3. Financial Performance
12.15.4. Recent Initiatives
12.16. Experian PLC
12.16.1. Company Overview
12.16.2. Product Offerings
12.16.3. Financial Performance
12.16.4. Recent Initiatives
12.17. NextGen Healthcare Information System LLC
12.17.1. Company Overview
12.17.2. Product Offerings
12.17.3. Financial Performance
12.17.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments